|
EDC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.004130E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6440199999912E-05 |
| Normal-vs-Stage2 |
8.105800E-02 |
| Normal-vs-Stage3 |
8.984400E-02 |
| Normal-vs-Stage4 |
1.654150E-01 |
| Stage1-vs-Stage2 |
4.269600E-01 |
| Stage1-vs-Stage3 |
1.083390E-01 |
| Stage1-vs-Stage4 |
2.565000E-01 |
| Stage2-vs-Stage3 |
6.699400E-01 |
| Stage2-vs-Stage4 |
7.062800E-01 |
| Stage3-vs-Stage4 |
9.504400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.34030000000929E-05 |
| Normal-vs-AfricanAmerican |
1.007930E-02 |
| Normal-vs-Asian |
4.476400E-01 |
| Caucasian-vs-AfricanAmerican |
4.949200E-01 |
| Caucasian-vs-Asian |
7.096400E-01 |
| AfricanAmerican-vs-Asian |
8.950600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14499999999784E-05 |
| Normal-vs-Female |
1.687780E-01 |
| Male-vs-Female |
2.576500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.576200E-02 |
| Normal-vs-Extreme_Weight |
2.19369999999719E-05 |
| Normal-vs-Obese |
5.241600E-03 |
| Normal-vs-Extreme_Obese |
3.012000E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.777600E-02 |
| Normal_Weight-vs-Obese |
6.546200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.995000E-01 |
| Extreme_Weight-vs-Obese |
7.212200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.034800E-01 |
| Obese-vs-Extreme_Obese |
8.885000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.343600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.896900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.56149999999533E-05 |
| Normal-vs-Age(81-100Yrs) |
5.55669999999786E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.894400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.797300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.739900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.930330E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.342500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.585420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.957600E-04 |
| Normal-VS-Type2 PRCC |
5.58179999999853E-05 |
| Normal-VS-KIRP CIMP |
6.722800E-01 |
| Normal-VS-Unclassified PRCC |
2.504300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.940210E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.454400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.354400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.591800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.800220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.020600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62081999999231E-05 |
| Normal-vs-N1 |
9.847200E-01 |
| Normal-vs-N2 |
5.040000E-01 |
| N0-vs-N1 |
3.900000E-03 |
| N0-vs-N2 |
1.969420E-01 |
| N1-vs-N2 |
6.656800E-01 |
|
|
